a point, at the same time they promise to help, they are blocking efforts by some local manufacturers and distributors from providing generic versions of their drugs at far lower cost.
There is validity to the argument, whether by a large corporation or an individual, that they (or he) should be able to profit from their innovative creations, regardless of the length of time that product, service, or creation is available to the public.
This, then, also comes to a climax of ethics and morality, especially in the medical field. When a magazine article boldly states that "In AIDS-stricken Africa, the enforcement of Western drug patents is a needless death sentence for millions" (Shulman,
...